FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jovan Antovic

Research Profile

Chemicals & Drugs

Physiology

Procedures

Disorders

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
F Mobarrez; Danijela Mikovic; Aleksandra Antovic; Jovan P Antovic
Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?
Jovan P Antovic; J Eintrei; G Forslund; K Höög Hammarström; Margareta Sten-Linder
Comparison of five point-of-care D-dimer assays with the standard laboratory method.
Jovan P Antovic; Ivo Elezovic; Petra Elfvinge; Margareta Holmström; Nida Mahmoud Hourani Soutari; Danijela Mikovic; Matthias Wilkens; Aleksandra Antovic
Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jovan Antovic (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: F Mobarrez; Danijela Mikovic; Aleksandra Antovic; Jovan P Antovic
Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?
Journal of thrombosis and haemostasis : JTH 2013;11(4):697-703.
2012: Jovan P Antovic; J Eintrei; G Forslund; K Höög Hammarström; Margareta Sten-Linder
Comparison of five point-of-care D-dimer assays with the standard laboratory method.
International journal of laboratory hematology 2012;34(5):495-501.
2012: Jovan P Antovic; Ivo Elezovic; Petra Elfvinge; Margareta Holmström; Nida Mahmoud Hourani Soutari; Danijela Mikovic; Matthias Wilkens; Aleksandra Antovic
Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A.
Thrombosis and haemostasis 2012;108(1):21-31.
2012: Danijela Mikovic; F Mobarrez; B J Woodhams; Aleksandra Antovic; Ivo Elezovic; P Elfvinge; M Holmström; Jovan P Antovic
On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients.
International journal of laboratory hematology 2012;34(1):35-40.
2011: Riitta Lassila; Jovan P Antovic; Elina Armstrong; Fariba Baghaei; Joern Dalsgaard-Nielsen; Andreas Hillarp; Paul A Holme; Margareta Holmström; Hans Johnsson; Lotta Joutsi-Korhonen; Per Morten Sandset
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
Seminars in thrombosis and hemostasis 2011;37(3):328-36.
2010: Fariborz Mobarrez; Jovan P Antovic; Nils Egberg; Mona Hansson; Gun Jörneskog; Kjell Hultenby; Håkan Wallén
A multicolor flow cytometric assay for measurement of platelet-derived microparticles.
Thrombosis research 2010;125(3):e110-6.
2009: Mika Skeppholm; N Håkan Wallén; Fariborz Mobarrez; Alf Sollevi; Anne Soop; Jovan P Antovic
Inflammation and thrombin generation cause increased thrombin activatable fibrinolysis inhibitor levels in experimental human endotoxemia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(7):611-3.
2009: Slobodan D Obradovic; Jovan P Antovic; Nebojsa M Antonijevic; Nenad G Ratkovic; Danilo V Vojvodic; Vesna S Subota; Branko Lj Gligic; Dragana V Obradovic; Jelena M Marinkovic; Håkan N Wallen
Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(4):283-9.
2007: Elisabeth Rooth; Håkan N Wallen; Aleksandra Antovic; Magnus von Arbin; Georgios Kaponides; Nils Gunnar Wahlgren; Margareta Blombäck; Jovan P Antovic
Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(4):365-70.
2007: Mika Skeppholm; N Håkan Wallén; Karin Malmqvist; Anders Kallner; Jovan P Antovic
Comparison of two immunochemical assays for measuring thrombin-activatable fibrinolysis inhibitor concentration with a functional assay in patients with acute coronary syndrome.
Thrombosis research 2007;121(2):175-81.
2007: Michael Nekludov; Jovan P Antovic; Sixten Bredbacka; Margareta Blombäck
Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers.
Journal of neurotrauma 2007;24(1):174-80.
2005: Jovan P Antovic
Thrombin activatable fibrinolysis inhibitor antigen could not be detected in cerebrospinal fluid.
Thrombosis and haemostasis 2005;93(1):178-9.
2004: Jovan P Antovic; Aleksandra Antovic; Margareta Sten-Linder; ML Wramsby; Margareta Blombäck
Overall hemostatic potential (OHP) assay-a possible tool for determination of prothrombotic pattern in FXII deficiency.
Journal of thrombosis and haemostasis : JTH 2004;2(11):2058-60.
2004: Johanna S Ungerstedt; Jovan P Antovic; Margareta Blombäck; K Bremme; H Johnsson
Antithrombin antigen and activity in patients with acquired antithrombin deficiency-is there a difference?
Journal of thrombosis and haemostasis : JTH 2004;2(5):838-9.
2004: Jovan P Antovic; S Schulman; S S A An; R S Greenfield; Margareta Blombäck
Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?
Scandinavian journal of clinical and laboratory investigation 2004;64(8):745-51.
2003: Jovan P Antovic; Aleksandra Antovic
Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay.
Thrombosis and haemostasis 2003;90(4):620-7.
2003: Jovan P Antovic; Marianne Yngen; Claes-Göran G Ostenson; Aleksandra Antovic; Håkan N Wallen; Gun Jorneskög; Margareta Blombäck
Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(6):551-6.
2003: Jovan P Antovic
Thrombin activatable fibrinolysis inhibitor (TAFI). A link between coagulation and fibrinolysis.
Clinical laboratory 2003;49(9-10):475-86.
2002: Jovan P Antovic; Aleksandra Antovic; Shu He; L Tengborn; Margareta Blombäck
Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(6):781-6.
2002: Jovan P Antovic; Rangeen Rafik Hamad; Aleksandra Antovic; Margareta Blombäck; Katarina Bremme
Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
Thrombosis and haemostasis 2002;88(4):644-7.
2002: Jovan P Antovic; Margareta Blombäck
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
Thrombosis research 2002;106(1):59-62.
2002: Johanna S Ungerstedt; Sam Schulman; Nils Egberg; Jovan P Antovic; Nargareta Blombäck
Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?
Blood 2002;99(6):2271-2.
2002: Jovan P Antovic; M Bakic; M Zivkovic; A Ilic; Margareta Blombäck
Blood coagulation and fibrinolysis in acute ischaemic and haemorrhagic (intracerebral and subarachnoid haemorrhage) stroke: does decreased plasmin inhibitor indicate increased fibrinolysis in subarachnoid haemorrhage compared to other types of stroke?
Scandinavian journal of clinical and laboratory investigation 2002;62(3):195-9.
2001: Jovan P Antovic; S Schulman; A Eelde; Margareta Blombäck
Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2001;7(6):557-60.
2001: Jovan P Antovic; J Söderström; B Karlman; Margareta Blombäck
Evaluation of a new immunoturbidimetric test (Liatest antithrombin III) for determination of antithrombin antigen.
Clinical and laboratory haematology 2001;23(5):313-6.
2001: Jovan P Antovic; M Bakic; R Milicevic; G Gojkovic; Margareta Blombäck
Activation of the coagulation system occurs within rather than outside cutaneous haemangiomas.
Acta paediatrica (Oslo, Norway : 1992) 2001;90(10):1137-40.